What Is Vitiligo? PDF Print E-mail
Wednesday, 04 November 2009 19:37
According to the MayoClinic Staff, Vitiligo (vit-ih-LI-go) is a condition in which your skin loses melanin, the pigment that determines the color of your skin, hair and eyes. Vitiligo occurs when the cells that produce melanin die or no longer form melanin, causing slowly enlarging white patches of irregular shapes to appear on your skin. Exactly why this occurs isn't known.

Vitiligo affects all races, but may be more noticeable and disfiguring in people with darker skin. Vitiligo usually starts as small areas of pigment loss that spread with time. These changes in your skin can result in stress and worries about your appearance. Like Scleroderma, there is no cure for vitiligo.

The goal of treatment is to stop or slow the progression of pigment loss and, if you desire, attempt to return some color to your skin.

Although any part of your body may be affected by Vitiligo, depigmentation usually develops first on sun-exposed areas of your skin, such as your hands, feet, arms, face and lips. Although it can start at any age, Vitiligo often first appears between the ages of 10 and 30.

The natural course of Vitiligo is difficult to predict. Sometimes the patches stop forming without treatment. But, in most cases, pigment loss spreads and can eventually involve most of the surface of your skin.

taken from http://www.flickr.com/photos/40097140@N02/3798426328/ via creative commonsDoctors and scientists have theories as to what causes Vitiligo. It may be due to an immune system disorder. Heredity may be a factor because there's an increased incidence of Vitiligo in some families. Some people have reported a single event, such as sunburn or emotional distress, that triggered the condition. However, none of these theories has been proven as a definite cause of Vitiligo.

Vitiligo is the most likely diagnosis in cases in which there is a progressive depigmentation leading to symmetrically distributed, chalk-white macules on the face, neck, scalp, mucous membranes, or periorificial areas, and not accompanied by any other symptom. This is essentially what differentiates Vitiligo from Scleroderma.

Diffuse scleroderma may result in areas of skin hypopigmentation. However, systemic signs of Scleroderma include essential vasomotor disturbances, such as Raynaud's phenomenon, fibrosis, and abnormalities of the lungs, kidneys, digestive system, and heart.

For more information on Vitiligo, you're welcome to view the MayoClinic's full article here, or visit the Vitiligo Foundation here. The International Scleroderma Network has some excellent links to additional resources on Vitiligo, such as diagnoses, personal stories and more. Similarly, there are many research papers on Vitiligo, one of which you can read here.
 
More articles :

» Diagnosis, Management and Prevention of Scleroderma Renal Disease

Henry Penn; Christopher P. DentonPosted: 11/14/2008; Curr Opin Rheumatol. 2008;20(6):692-696. © 2008 Lippincott Williams & WilkinsPurpose of Review: Renal complications are important in scleroderma (systemic sclerosis) and include scleroderma...

» Unite Against Scleroderma 2012

{gallery}unite3{/gallery}

» What is Chelation Therapy?

Chelation (pronounced key-LAY-shun) therapy is a chemical process in which a synthetic solution-EDTA (ethylenediaminetetraacetic acid) is injected into the bloodstream to remove heavy metals and/or minerals from the body. Chelation means "to grab"...

» Geneticists Hunt for Scleroderma Triggers

In all its forms, gives Dartmouth geneticist Michael Whitfield, his graduate students, and his postdoctoral researchers a sense of urgency in their search for the triggers of the chronic condition. In a study that the Journal of Investigative...

» GERD and Scleroderma

is an autoimmune disease that causes the skin, and sometimes other organs of the body, to become hard and thick. In the diffuse form of scleroderma, the esophagus and gastrointestinal tract are often affected. GERD, or gastroesophageal reflux...

» New Target Indentified In The Battle Against Rheumatoid Arthritis Identified

Researchers have uncovered the mechanism by which a cell signalling pathway contributes to the development of rheumatoid arthritis (RA). The study led by researchers at Hospital for Special Surgery, also provides proof that drugs under development...